Saturday, July 11, 2026

Drug profile · INN

tixagevimab and cilgavimab

tixagevimab and cilgavimab (EVUSHELD (NOTE 2)) is an FDA-listed pharmaceutical active ingredient.

PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — tixagevimab and cilgavimab
Class
Route
Patents
0
Programs
0
Data quality
0.78

Quick answer

tixagevimab and cilgavimab (EVUSHELD (NOTE 2)) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN tixagevimab and cilgavimab
Brand EVUSHELD (NOTE 2)

Approval history

Authority Status Date
PMDA approved

Frequently asked questions

What is tixagevimab and cilgavimab?

tixagevimab and cilgavimab (EVUSHELD (NOTE 2)) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for tixagevimab and cilgavimab?

EVUSHELD (NOTE 2) is a marketed brand name for tixagevimab and cilgavimab. Check FDA Drugs@FDA for the current US label holder and prescribing information.